• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长期左旋多巴治疗对经或未经6-羟基多巴胺预处理的小鼠脑脂质过氧化的不同影响。

Differential effects of chronic L-dopa treatment on lipid peroxidation in the mouse brain with or without pretreatment with 6-hydroxydopamine.

作者信息

Ogawa N, Asanuma M, Kondo Y, Kawada Y, Yamamoto M, Mori A

机构信息

Department of Neuroscience, Institute of Molecular and Cellular Medicine, Okayama University Medical School, Japan.

出版信息

Neurosci Lett. 1994 Apr 25;171(1-2):55-8. doi: 10.1016/0304-3940(94)90603-3.

DOI:10.1016/0304-3940(94)90603-3
PMID:8084500
Abstract

Whether or not chronic L-dopa treatment (100 mg/kg, intraperitoneally (i.p.), twice daily for 4 weeks) alters lipid peroxidation in the brain as an indicator of neuronal damage was examined in normal mice and mice in which catecholamine (CA) neurons had been injured previously by the administration of 6-hydroxydopamine (6-OHDA), followed by recovery. In normal mice, chronic L-dopa treatment reduced the thiobarbituric acid reacting substances (TBARS) level, an indicator of lipid peroxidation, in the cerebral cortex. In contrast, in mice with CA neuronal injury induced by pretreatment with 6-OHDA, the chronic L-dopa treatment markedly increased the TBARS in the striatum and frontal cortex, despite recovery of the striatal dopamine levels similar to those in the control mice. These findings suggest that the long-term high-dose administration of L-dopa enhances the progression of neuronal damage in patients with injured CA neurons such as those with Parkinson's disease.

摘要

研究了慢性左旋多巴治疗(100毫克/千克,腹腔注射(i.p.),每日两次,共4周)是否会改变大脑中的脂质过氧化作用,以此作为神经元损伤的指标,实验对象为正常小鼠以及先前通过注射6-羟基多巴胺(6-OHDA)损伤儿茶酚胺(CA)神经元后恢复的小鼠。在正常小鼠中,慢性左旋多巴治疗降低了大脑皮层中硫代巴比妥酸反应物质(TBARS)水平,这是脂质过氧化作用的一个指标。相比之下,在经6-OHDA预处理诱导CA神经元损伤的小鼠中,尽管纹状体多巴胺水平恢复到与对照小鼠相似,但慢性左旋多巴治疗显著增加了纹状体和额叶皮层中的TBARS。这些发现表明,长期高剂量施用左旋多巴会加速患有CA神经元损伤的患者(如帕金森病患者)的神经元损伤进程。

相似文献

1
Differential effects of chronic L-dopa treatment on lipid peroxidation in the mouse brain with or without pretreatment with 6-hydroxydopamine.长期左旋多巴治疗对经或未经6-羟基多巴胺预处理的小鼠脑脂质过氧化的不同影响。
Neurosci Lett. 1994 Apr 25;171(1-2):55-8. doi: 10.1016/0304-3940(94)90603-3.
2
Docosahexaenoic acid ethyl ester enhances 6-hydroxydopamine-induced neuronal damage by induction of lipid peroxidation in mouse striatum.二十二碳六烯酸乙酯通过诱导小鼠纹状体脂质过氧化增强6-羟基多巴胺诱导的神经元损伤。
Neurochem Res. 2009 Jul;34(7):1299-303. doi: 10.1007/s11064-008-9909-0. Epub 2009 Feb 15.
3
Dopamine agonist cabergoline inhibits levodopa-induced caspase activation in 6-OHDA-lesioned mice.多巴胺激动剂卡麦角林可抑制6-羟基多巴胺损伤小鼠中左旋多巴诱导的半胱天冬酶激活。
Neurosci Res. 2005 Jan;51(1):9-13. doi: 10.1016/j.neures.2004.09.002.
4
'Priming' enhances the relationship of striatal L-dopa concentration to behavior.“启动”增强了纹状体左旋多巴浓度与行为之间的关系。
Neuroreport. 1994 Aug 15;5(13):1665-9. doi: 10.1097/00001756-199408150-00031.
5
Salicylic acid protects against chronic L-DOPA-induced 6-OHDA generation in experimental model of parkinsonism.水杨酸可预防帕金森病动物模型中慢性 L-DOPA 诱导的 6-OHDA 生成。
Brain Res. 2010 Jul 16;1344:192-9. doi: 10.1016/j.brainres.2010.05.010. Epub 2010 May 12.
6
L-3,4-dihydroxyphenylalanine-induced dopamine release in the striatum of intact and 6-hydroxydopamine-treated rats: differential effects of monoamine oxidase A and B inhibitors.左旋多巴诱导完整及6-羟基多巴胺处理大鼠纹状体中多巴胺释放:单胺氧化酶A和B抑制剂的不同作用
J Neurochem. 1994 Jul;63(1):108-17. doi: 10.1046/j.1471-4159.1994.63010108.x.
7
Pergolide potentiates L-DOPA-induced dopamine release in rat striatum after lesioning with 6-hydroxydopamine.在用6-羟基多巴胺损伤大鼠纹状体后,培高利特可增强左旋多巴诱导的多巴胺释放。
J Neural Transm (Vienna). 1999;106(2):145-58. doi: 10.1007/s007020050147.
8
Reserpine pretreatment prevents increases in extracellular striatal dopamine following L-DOPA administration in rats with nigrostriatal denervation.利血平预处理可防止黑质纹状体去神经支配大鼠给予左旋多巴后纹状体细胞外多巴胺的增加。
J Neurochem. 2000 Jan;74(1):263-9. doi: 10.1046/j.1471-4159.2000.0740263.x.
9
Dopaminergic functional supersensitivity: effects of chronic L-dopa and carbidopa treatment in an animal model of Parkinson's disease.多巴胺能功能超敏反应:慢性左旋多巴和卡比多巴治疗在帕金森病动物模型中的作用。
J Pharmacol Exp Ther. 1993 Dec;267(3):1105-11.
10
Acute L-DOPA pretreatment potentiates 6-hydroxydopamine-induced toxic effects on nigro-striatal dopamine neurons in mice.急性左旋多巴预处理增强6-羟基多巴胺对小鼠黑质纹状体多巴胺神经元的毒性作用。
Brain Res. 1995 Dec 1;701(1-2):151-7. doi: 10.1016/0006-8993(95)00988-7.

引用本文的文献

1
Elucidating the Beneficial Effects of Ginger ( Roscoe) in Parkinson's Disease.阐明姜(Roscoe)对帕金森病的有益作用。
ACS Pharmacol Transl Sci. 2022 Sep 7;5(10):838-848. doi: 10.1021/acsptsci.2c00104. eCollection 2022 Oct 14.
2
Methamphetamine Dysregulation of the Central Nervous System and Peripheral Immunity.甲基苯丙胺对中枢神经系统和外周免疫的调节作用。
J Pharmacol Exp Ther. 2021 Dec;379(3):372-385. doi: 10.1124/jpet.121.000767. Epub 2021 Sep 17.
3
1-Benzyl-1,2,3,4-tetrahydroisoquinoline, an endogenous neurotoxic compound, disturbs the behavioral and biochemical effects of L-DOPA: in vivo and ex vivo studies in the rat.
1-苄基-1,2,3,4-四氢异喹啉,一种内源性神经毒性化合物,干扰左旋多巴的行为和生化效应:大鼠体内和体外研究
Neurotox Res. 2014 Oct;26(3):240-54. doi: 10.1007/s12640-014-9476-x. Epub 2014 May 20.
4
Recent advances on the neuroprotective potential of antioxidants in experimental models of Parkinson's disease.帕金森病实验模型中抗氧化剂神经保护潜力的最新进展。
Int J Mol Sci. 2012;13(8):10608-10629. doi: 10.3390/ijms130810608. Epub 2012 Aug 23.
5
Effects of zingerone [4-(4-hydroxy-3-methoxyphenyl)-2-butanone] and eugenol [2-methoxy-4-(2-propenyl)phenol] on the pathological progress in the 6-hydroxydopamine-induced Parkinson's disease mouse model.荜澄茄酮[4-(4-羟基-3-甲氧基苯基)-2-丁酮]和丁香酚[2-甲氧基-4-(2-丙烯基)苯酚]对 6-羟多巴胺诱导的帕金森病小鼠模型中病理进程的影响。
Neurochem Res. 2011 Dec;36(12):2244-9. doi: 10.1007/s11064-011-0548-5. Epub 2011 Jul 19.
6
Levodopa therapy from the neuroprotection viewpoint. From a clinical outlook.从神经保护角度看左旋多巴疗法。从临床角度来看。
J Neurol. 2005 Oct;252 Suppl 4:IV32-IV36. doi: 10.1007/s00415-005-4007-6.
7
Dopamine- or L-DOPA-induced neurotoxicity: the role of dopamine quinone formation and tyrosinase in a model of Parkinson's disease.多巴胺或左旋多巴诱导的神经毒性:多巴胺醌形成和酪氨酸酶在帕金森病模型中的作用
Neurotox Res. 2003;5(3):165-76. doi: 10.1007/BF03033137.
8
Levodopa in Parkinson's disease: neurotoxicity issue laid to rest?帕金森病中的左旋多巴:神经毒性问题已得到解决?
Drug Saf. 1999 Nov;21(5):339-52. doi: 10.2165/00002018-199921050-00001.
9
Induction of apoptosis in catecholaminergic PC12 cells by L-DOPA. Implications for the treatment of Parkinson's disease.
J Clin Invest. 1995 Jun;95(6):2458-64. doi: 10.1172/JCI117946.